Reyes JAE, González GJ, Landgrave GI, Castro DLJ, Pérez GAC, Espinosa LFR

Language: Spanish
References: 33
Page: 461-467
PDF size: 269.31 Kb.

ABSTRACT

Although the eosinophiles are normal lung components, several lung eosinophilic syndromes are characterized by an increased number of eosinophiles in peripheral blood, pulmonary tissue, sputum, or bronchoalveolar lavage.
These lung eosinophilic syndromes are generally characterized by respiratory symptoms, chest x - ray disturbances, and potential systemic manifestations.
The eosinophile plays an important role in each one of these syndromes; it is often difficult to distinguish between them. However there are important clinical differences and treatment paradigms, so it is important to understand and to appreciate the features that distinguish each one of these conditions.
This article summarizes the clinical manifestations of these syndromes, the differences between them and the diagnostic approach to the patient with eosinophilia and lung disease.

REFERENCES

1. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324:1110-8.

2. Simon D, Simon HU. Eosinophilic disorders. J Allergy Clin Immunol 2007;119:1291-300.

3. Loffler W. Zur differential-diagnose der lungeninfiltriemungen. II. Uber fluchtige succedan-infiltrate (mit eosinophilie). Beitr Klin Tuberk 1932; 79:368-92.

4. Allen JN, Magro CM, King MA. The eosinophilic pneumonias, Sem in Resp and Crit Care Med 2002; 2(23):127-34.

5. Allen J. Eosinophilic lung diseases. (online) 2004; En: http://www.chestnet.org/education/online/pccu/vol 18/lesson 13-14/lesson 14.php

6. Badesch DB, King TE, Schwarz MI. Acute eosinophilic pneumonia: a hypersensitivity phenomenon. Am Rev Respir Dis 1989;139:249-52.

7. Allen JN, Pacht ER, Gadek JE, et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989;321:569-74.

8. Philit F, Etienne-Mastroianni B, Parrot A, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. The Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMO’P). Am J Respir Crit Care Med 2002;166:1235-9.

9. Goetzl E, Luce J. Eosinophilic lung diseases. En: Murray J, Nadel J. Textbook of Respiratory Medicine. Filadelfia: Saunders 2000: 1757-73.

10. Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 2005;60:841-57.

11. Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Engl J Med 1969;280:787–98.

12. Jederlinic PJ, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 1988;67:154-62.

13. Arakawa H, Kurihara Y, Niimi H, et al. Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: high-resolution CT findings in 81 patients. Am J Roentgenol 2001;176:1053-8.

14. Marchand E, Reynaud-Gaubert M, Lauque D, et al. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe ’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMO’P). Medicine (Baltimore) 1998;77:299-312.

15. Eric Marchand and Jean-François Cordier. Orphanet Journal of Rare Diseases 2006, 1:11

16. Churg J, Strauss L. Allergic angiitis and periarteritis nodosa. Am J Pathol 1951;27:277-301.

17. Martin RM, Wilton LV, Mann RD. Prevalence of Churg–Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf 1999; 8:179-89.

18. Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 2005;19:191-207.

19. Hattori N, Ichimura M, Nagamatsu M, et al. Clinicopathological features of Churg–Strauss syndrome-associated neuropathy. Brain 1999;122:427-39.

20. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg- Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33(8):1094-100.

21. Lanham JG, Elkon KB, Pusey CD, et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1983;63:65-81.

22. Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine 1999;78:26-37.

23. Conron M, Beynon HLC. Churg-Strauss syndrome. Thorax 2000;55:870-7.

24. Hagen EC, Daha MR, Hermans J, et al. The diagnostic value of standardized assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998;53:743-53.

25. Choi YH, Im JG, Han BK, et al. Thoracic manifestations of Churg-Strauss syndrome. Chest 2000;117:117-24.

26. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA1998; 279:455-7.

27. Wechsler ME, Finn D, Gunawardena D, et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000;117:708-13.

28. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423-38.

29. Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006;117:1292-302.

30. Chusid MJ, Dale DC, West BC, et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54(1):1-27.

31. Klion AD. Recent advances in the diagnosis and treatment of hypereosinophilic syndromes. Hematology 2005;209-14.

32. Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 2005;60:841-57.

33. Roufosse F, Cogan E, Goldman M. Recent advances in the pathogenesis and management of hypereosinophilic syndromes. Allergy 2004;59:673-89.